Search Results

1 - 10 of 1,194 items :

  • breast cancer x
Clear All
Breast Cancer in Art Painting

References Baljet, B. 2000. The painted Amsterdam anatomy lessons: anatomy performances in dissecting rooms? Ann. Anat. 182: 3-11. Batistatou, A., Charalabopoulos, K. A. 2005. The art of science: Transitional cell carcinoma of the bladder and Golconda. Med. Hypotheses 65: 970-971. Baum, M. 2003. La Fornarina: breast cancer or not? Lancet 361: 1129. Belkin, K. L., Healy, F. Martin, G. 2004. Painting and sculpture. In: K. L. Belkin, F. Healy (eds), A house of

Open access
Oncoplastic breast surgery techniques - a new look at surgical treatment of breast cancer

REFERENCES 1. Madej-Czerwonka BT. Standards in breast surgery – Breast Units – future and necessity. Contemp Oncol. 2014;18(4):227-9. 2. Wojciechowska U, Didkowska J. Cancer in Poland in 2012. Nowotwory. 2013;63(3):197-216. 3. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347(16):1227-32. 4. Munhoz AM, Aldrighi CM, Ferreira MC. Paradigms in oncoplastic breast surgery

Open access
Incidence and location of bone metastases in breast cancer

(4),302. 5. McPherson K, Steel C, Dixon JM. ABC of breast diseases: breast cancer—epidemiology, risk factors, and genetics. BMJ: British Medical Journal. 2000; 321(7261),624. 6. Abrams HL. Skeletal metastases in carcinoma. Radiology. 1950; 55:534–538,3. 7. Rivkees A, Crawford J. The relationship of gonadal activity and chemotherapy-induced gonadal damage. JAm Med Assoc. 1988; 259:2123-5. 8. Saarto T et al. Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by c1

Open access
Natural product like “shikonin” might be a hope for Breast cancer cure

References [1] R. Yuan, Y. Hou, W. Sun, J. Yu, X. Liu, Y. Niu, J.J. Lu, and X. Chen, “Natural products to prevent drug resistance in cancer chemotherapy: a review”, Annals of the New York Academy of Sciences, 1401, 2017, 19-27 DOI: 10.1111/nyas.13387. [2] M.S. Donepudi, K. Kondapalli, S.J. Amos, and P. Venkanteshan, “Breast cancer statistics and markers”, Journal of cancer research and therapeutics, Vol. 10, 506, 2014. DOI: 10.4103/0973-1482.137927. [3] J. Xu, K. Koizumi, M. Liu, Y. Mizuno, M. Suzaki, H. Iitsuka, A. Inujima, M. Fujimoto, N

Open access
Effect of Breast Cancer on Physical Activity in Women

mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer 36(5), E359-E386. DOI: 10.1002/ijc.29210. 4. Kruk J. (2006). Fruit and vegetable consumption and the risk of breast cancer. Contemporary Oncology 10(5), 224-230. [in Polish] 5. Tyczyński J.E. (2003). Environmental risk factors for cancer and prevention opportunities (primary prevention). In A. Kułakowski, A. Skowrońska-Gardas (eds), Oncology. Handbook for medical students (pp. 21-27). Warszawa: PZWL. [in Polish] 6. Abdulkareem I.H. (2013

Open access
Ultrasound elastography as an objective diagnostic measurement tool for lymphoedema of the treated breast in breast cancer patients following breast conserving surgery and radiotherapy

References 1. Olivotto IA, Weir LM, Kim-Sing C, Bajdik CD, Trevisan CH, Doll CM, et al. Late cosmetic results of short fractionation for breast conservation. Radiother Oncol 1996; 41: 7-13. 2. Aryana K, Gholizadeh M, Momennezhad M, Naji M, Aliakbarian M, Forghani MN, et al. Efficacy of high-energy collimator for sentinel node lymphoscintigraphy of early breast cancer patients. Radiol Oncol 2012; 46: 75-80. 3. Kelemen G, Varga Z, Lázár G, Thurzó L, Kahán Z. Cosmetic outcome 1-5 years after breast

Open access
Associations of pathogenic mutations responsible for breast cancer risk with histology and immunohistochemistry in Romanian population

References 1. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013; 49(6):1374-403. DOI: 10.1016/j.ejca.2012.12.027 2. Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science. 1990; 250(4988):1684-9. DOI: 10.1126/science.2270482 3. Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D

Open access
Male Breast Cancer – Actuality of Our Days

References 1. van Geel AN, van Slooten EA, Mavrunac M & Hart AA. (1985). A retrospective study of male breast cancer in Holland . Br J Surg. 72, 724-727. 2. Silverberg E & Lubero J. (1987): Cancer Statistics. CA. 37,2-19. 3. Haagensen CD. (1985). Diseases of the Breast (ed 3). Philadelphia: WB Saunders. 4. Ajayi DO, Oseghe DN & Ademiluyi SA. (1982). Carcinoma of the male breast in West Africans and a review of world literature. Cancer. 50,1664-1667. 5. Nirmul D, Pegoraro, RJ, Naidoo C & Joubert SM. (1983). The sex hormone profile of male

Open access
Breast Cancer - Clinical Implication

References American Cancer Society. Cancer fact sand figures, 2001-2002. Atlanta, Georgia: American Cancer Society at: http://www.cancer.org Advisory Committee on Cancer Prevention. Recomendation on cancer screening in the European Union. European Journal of Cancer 2000; 36 : 1473-78. Filipović S. Osnovi kliničke onkologije. Prosveta 1996; 21-27. Sewell CW. Pathology of high risk breast leisions and ductal carcinoma in situ. Radiologic Clinics of North

Open access
Cardiotoxicity of concomitant radiotherapy and trastuzumab for early breast cancer

References 1. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987; 235: 177-82. 2. Romond EH, Perez EA, Bryant J, Suman VJ, Geyer CE Jr, Davidson NE, et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 2005; 353: 1673-84. 3. Smith I, Procter M, Gelber RD, Guillaume S, Feyereislova A, Dowsett M, et al. 2-year follow-up of trastuzumab

Open access